Ae Aflibercept (Genetically Recombination) (8 Mg 0.07 Ml/Bottle) 960 Bottles

国立大学法人 Japan has Released a tender for Ae Aflibercept (Genetically Recombination) (8 Mg 0.07 Ml/Bottle) 960 Bottles in Healthcare and Medicine. The tender was released on Aug 01, 2024.

Country - Japan

Summary - Ae Aflibercept (Genetically Recombination) (8 Mg 0.07 Ml/Bottle) 960 Bottles

Deadline - login to view

MT reference number - 90028052

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Japan

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90028052

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Tender announcementThe following items will be subject to public competitive bidding.August 1, 2024Shojiro Nishio, President, Osaka University, National University Corporation◎Procurement agency number: 415◎Location number: 27○No. 521. Procurement details⑴ Item classification number: 4⑵ Purchasing item and planned quantityAE Aflibercept (recombinant) (8 mg 0.07 ml/bottle) 960 bottles⑶ Characteristics of procurement items: See bidding instructions.⑷ Delivery deadline: October 1, 2024 to March 31, 2025⑸ Delivery location: Osaka University Hospital⑹ Bidding method: Each item in 1⑵ above will be subject to bidding. The bid amount should be the unit price for each

Mt Ref Id - 90028052

Deadline - Aug 16, 2024

Share

Similar Tenders :